Quarterly report [Sections 13 or 15(d)]

Stockholders’ Equity (Details Narrative)

v3.26.1
Stockholders’ Equity (Details Narrative) - USD ($)
6 Months Ended
Nov. 13, 2025
Dec. 24, 2024
Jun. 22, 2022
Jun. 30, 2026
Jun. 30, 2025
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares granted       893,181  
Number of additional granted shares issued       120  
Aggregate vested shares value       $ 2,009,657  
Number of unvested shares       15,181  
Unrecognized value of shares       $ 34,157  
2019 Equity Incentive Plan [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares granted     1,498,128    
Exercise price     $ 7.63    
Stock granted       $ 9,512,356  
Risk-free rate       3.20%  
Volatility rate       106.00%  
Compensation expense       $ 9,512,356  
Fair value         $ 7,193,716
2024 Equity Incentive Plan [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares granted 100,000 1,627,937      
Exercise price $ 8.20 $ 12.16      
Stock granted $ 626,469 $ 16,190,565      
Risk-free rate 3.70% 4.50%      
Volatility rate 101.00% 103.00%      
Compensation expense $ 626,469     10,573,391  
Fair value       $ 5,617,174 $ 6,774,623
ATM Agreement [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares issued       379,762 320,210
Public offering price       $ 25.36 $ 9.95
Gross proceeds from sale of shares       $ 9,629,468 $ 3,185,661
Net proceeds from sale of shares       9,340,576 3,100,668
Underwriting discounts, commissions and offering expenses       $ 288,892 $ 84,993
Common Stock [Member]          
Accumulated Other Comprehensive Income (Loss) [Line Items]          
Number of shares granted       908,362  
Common stock grant vested shares       0 0